Related Experiment Video
Updated: Oct 27, 2025
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector
Wataru Matsunaga1, Katsuyuki Hamada2,3, Masatoshi Tagawa4
1Joint-use Research Facilities, Hyogo College of Medicine, Nishinomiya, Japan.
Background:
The clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) is thought to have promising clinical potential. However, the off-target effects of Cas9 are a major concern for its application. Therefore, we hypothesized that the adverse effects of off-target gene editing might be minimized if the human codon-optimized Streptococcus pyogenes Cas9 (hCas9) could be specifically expressed in cancer cells.
Materials And Methods:
We constructed a chimeric adenoviral vector, Ad5F35-MKp-hCas9, and infected human bladder cancer cell lines with this vector. The confirmation of hCas9 gene expression was performed in 3-4 days after from infection.
Results:
hCas9 gene expression was observed in Ad5F35-MKp-hCas9 infected bladder cancer cells but not in non-malignant cells.
Conclusion:
Our study showed that the Ad5F35-MKp-hCas9 vector is capable of expressing the hCas9 gene with high specificity in bladder cancer cells. These findings may help in minimizing the risk of off-target effects of gene editing.
Insights
This study developed a targeted gene editing approach using a specialized adenoviral vector to express human codon-optimized Streptococcus pyogenes Cas9 (hCas9) specifically in cancer cells, reducing off-target concerns.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Editing Technologies
Background:
- Clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) shows clinical promise but faces challenges due to off-target effects.
- Minimizing off-target gene editing is crucial for safe and effective clinical applications of CRISPR-Cas9 technology.
Purpose of the Study:
- To investigate the specific expression of human codon-optimized Streptococcus pyogenes Cas9 (hCas9) in cancer cells.
- To hypothesize that targeted hCas9 expression can minimize adverse effects of off-target gene editing.
Main Methods:
- Construction of a chimeric adenoviral vector, Ad5F35-MKp-hCas9.
- Infection of human bladder cancer cell lines with the constructed vector.
- Confirmation of hCas9 gene expression post-infection.
Main Results:
- hCas9 gene expression was successfully detected in Ad5F35-MKp-hCas9 infected bladder cancer cells.
- No hCas9 gene expression was observed in non-malignant cells, indicating high specificity.
Conclusions:
- The Ad5F35-MKp-hCas9 vector demonstrates high specificity for expressing hCas9 in bladder cancer cells.
- This targeted approach holds potential for minimizing off-target effects in gene editing therapies.
